XML 53 R12.htm IDEA: XBRL DOCUMENT

Goodwill And Intangible Assets

3 Months Ended

Mar. 31, 2013

(6) Goodwill and Intangible Assets

The changes in the carrying amount of goodwill for the three months ended March 31, 2013 and 2012 are as follows (in thousands):

		Three Months Ended
		March 31,
		2013		2012

Balance, beginning of period		$	1,652,002	$	1,229,298
Goodwill acquired, including post acquisition adjustments			(2,702)		11,911
Goodwill disposed, including impact of deconsolidation transaction			(2,120)		(787)

	Balance, end of period	$	1,647,180	$	1,240,422

Amortizable intangible assets at March 31, 2013 and December 31, 2012 consisted of the following (in thousands):

		March 31, 2013						December 31, 2012
		Gross						Gross
		Carrying		Accumulated				Carrying		Accumulated
		Amount		Amortization		Net		Amount		Amortization		Net

Deferred financing cost		$	14,536	$	(3,519)	$	11,017	$	14,523	$	(3,029)	$	11,494
Agreements, contracts and other intangible assets			3,448		(2,305)		1,143		3,448		(2,250)		1,198

	Total amortizable intangible assets	$	17,984	$	(5,824)	$	12,160	$	17,971	$	(5,279)	$	12,692

Amortization of intangible assets for the three months ended March 31, 2013 and 2012 was $545,000 and $314,000, respectively. Estimated amortization of intangible assets for the remainder of 2013 and the following five years and thereafter is $1,753,000, $2,334,000, $2,333,000, $2,332,000, $1,514,000, $939,000 and $955,000, respectively. The Company expects to recognize amortization of intangible assets over a weighted average period of 5.6 years.

At March 31, 2013 and December 31, 2012, other non-amortizable intangible assets related to restrictive covenant arrangements were $9,825,000, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details